Eli Lilly’s Push Beyond Weight Loss Gets Another Boost – FDA Grants Cancer Drug Orphan Drug Status
The designation, given to therapies being developed for rare diseases, enables Lilly to receive potential incentives, including clinical trial tax credits, exemption from certain FDA fees, and exclusivity.